Breakthroughs with daraxonrasib in pancreatic cancer pave the way for continued investment in understanding the fundamental biology of cancers.
Tracy Proverbs-Singh, MD
Advertisement
Articles by Tracy Proverbs-Singh, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Key Questions on ADC Selection, Sequencing, and Toxicity Management Across Breast Cancer Subtypes
2
Subcutaneous Toripalimab Plus Disitamab Vedotin sNDA Is Accepted in China for HER2-Expressing Urothelial Cancer
3
Broadening HER2-Mutated NSCLC Data Support First-Line Zongertinib Followed by T-DXd
4
Lirafugratinib Associated With More Mucocutaneous AEs After Prior ICIs in FGFR2-Altered CCA and Other Solid Tumors
5